Battle over authorized generics grows increasingly heated
Everyone knows market competition isn't pretty, but the battle between Big Pharma and generic manufacturers is often downright nasty. That's especially true as some generic companies fight Big Pharma—and one another—to stop a practice they find particularly abhorrent: authorized generics. The only thing everyone agrees about is that no one knows where the issue goes from here—to Congress or the Supreme Court.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
